One-A-Day is a-okay, NAD says
This article was originally published in The Tan Sheet
Product claims asserting Bayer Healthcare's One-A-Day Women's Multi-Vitamin may reduce breast cancer risks due to its higher Vitamin D content are substantiated, the National Advertising Division of the Council of Better Business Bureaus says. The phrase "breast health" is reasonably interpreted by consumers to mean the health benefits of Vitamin D may reduce breast cancer, NAD says. Bayer's multivitamin contains 800 international units of vitamin D per dose. The company said it is "pleased that NAD has found our ad for One-A-Day Women's adequately substantiated"...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.